Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangxi Simei Pharmaceutical is a China-based pharmaceutical company focused on the research, development, and large-scale production of chemical drugs and active pharmaceutical ingredients (APIs). Headquartered in Nanchang, the company operates advanced manufacturing facilities that adhere to national GMP standards, producing a wide range of oral solid dosages and raw materials. Its product portfolio primarily targets therapeutic areas such as cardiovascular diseases, infectious diseases, and metabolic disorders. Simei Pharmaceutical emphasizes a vertically integrated business model, combining internal R&D capabilities with robust manufacturing to supply both domestic and global markets. The company is recognized as a high-tech enterprise in Jiangxi Province, contributing to the regional pharmaceutical industry through continuous process optimization and quality control.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangxi Simei Pharmaceutical.